Blue Cross Blue Shield of Minnesota Medical Policy

 
 

Medical Policy:
II-95-004
Topic:
Catheter Ablation as Treatment for Atrial Fibrillation
Section:
Medicine
Effective Date:
April 27, 2020
Issued Date:
May 3, 2021
Last Revision Date:
April 2020
Annual Review:
April 2021
 
 

Atrial fibrillation (AF) frequently arises from an abnormal focus at or near the junction of the pulmonary veins and the left atrium, thus leading to the feasibility of more focused ablation techniques directed at these structures. Catheter-based ablation, using radiofrequency ablation (RFA) or cryoablation, is being studied as a treatment option for various types of AF. Circumferential pulmonary vein ablation using radiofrequency energy is the most common approach to catheter ablation. Cryoablation using a catheter to damage or destroy abnormal foci by applying extreme cold is also used. Other energy sources, such as laser, are under investigation for this indication.

AF can be subdivided into 3 types:

  • Paroxysmal (episodes that last <7 days and are self-terminating)
  • Persistent (episodes that last for >7 days and can be terminated pharmacologically or by electrical cardioversion)
  • Permanent

Although catheter ablation is a common treatment for atrial fibrillation, significant adverse events do occur. Studies report serious adverse event rates from 4% to 9% including vascular complications at the site of catheter insertion (usually groin) and more rarely, serious cardiovascular events such as tamponade, stroke, and death.

New York Heart Association (NYHA) Classification of Heart Failure:

The NYHA classification consists of 4 categories of heart failure based on a patient’s limitation during physical activity. 

Class Patient Symptoms
I No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath). 
II Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).
III Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea. 
IV Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.

Source: https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/classes-of-heart-failure

This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Policy Position Coverage is subject to the specific terms of the member's benefit plan.

I.   Transcatheter radiofrequency ablation or cryoablation to treat atrial fibrillation may be considered MEDICALLY NECESSARY AND APPROPRIATE when the following criteria are met:

  • Patient is symptomatic (e.g. palpitations fatigue, weakness, dizziness); AND ONE of the following:
    • AF is paroxysmal or persistent; or
    • As an alternative to atrioventricular nodal ablation and pacemaker insertion in patients with NYHA Class II or III congestive heart failure; AND
  • ONE of the following
    • Failure to respond to antiarrhythmic medications; or
    • Documented intolerance, FDA labeled contraindication, or hypersensitivity to conventional antiarrhythmic medications.

II.  Transcatheter radiofrequency ablation or cryoablation to treat atrial fibrillation may be considered MEDICALLY NECESSARY AND APPROPRIATE as an initial treatment for patients when BOTH of the following criteria are met:

  • Recurrent symptomatic paroxysmal atrial fibrillation (>1 episode, lasting up to 7 days, in the previous 6 months); AND
  • A rhythm-control strategy is desired.

III. Repeat radiofrequency ablation or cryoablation may be considered MEDICALLY NECESSARY AND APPROPRIATE when EITHER of the following are met:

  • Recurrence of atrial fibrillation after meeting criteria in I or II above; or
  • Development of atrial flutter following the initial procedure.

IV.  Transcatheter radiofrequency ablation or cryoablation as a treatment of atrial fibrillation that does not meet the criteria outlined above is considered EXPERIMENTAL/INVESTIGATIVE due to a lack of clinical evidence demonstrating an impact on improved health outcomes.

93656 93657 93799





Denial Statements

No additional statements.



Links





Blue Cross and Blue Shield of Minnesota medical policies apply generally to all Blue Cross and Blue Plus plans and products. Benefit plans vary in coverage and some plans may not provide coverage for certain services addressed in the medical policies. When determining coverage, reference the member’s specific benefit plan, including exclusions and limitations.

Medicaid products may provide different coverage for certain services, which may be addressed in different policies. For Minnesota Health Care Program (MHCP) policies, please consult the MHCP Provider Manual website.

Medicare products may provide different coverage for certain services, which may be addressed in different policies. For Medicare National Coverage Determinations (NCD), Local Coverage Determinations (LCD), and/or Local Coverage Articles, please consult CMS, National Government Services, or CGS websites. 

Note that services with specific coverage criteria may be reviewed retrospectively to determine if criteria are being met. Retrospective denial of claims may result if criteria are not met.

Blue Cross and Blue Shield of Minnesota reserves the right to revise, update and/or add to its medical policies at any time without notice. Codes listed on this policy are included for informational purposes only and are subject to change without notice. Inclusion or exclusion of a code does not constitute or imply member coverage or provider reimbursement. 

These guidelines are the proprietary information of Blue Cross and Blue Shield of Minnesota. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.

Acknowledgements:

CPT® codes copyright American Medical Association® 2022. All rights reserved.

CDT codes copyright American Dental Association® 2022. All rights reserved.